Hall Matthew G, Hauson Alexander O, Wollman Scott C, Allen Kenneth E, Connors Eric J, Stern Mark J, Kimmel Christine L, Stephan Rick A, Sarkissians Sharis, Barlet Brianna D, Grant Igor
a Clinical Psychology PhD Program, California School of Professional Psychology , San Diego , CA , USA.
b Institute of Brain Research and Integrated Neuropsychological Services (iBRAINs.org) , San Diego , CA , USA.
Am J Drug Alcohol Abuse. 2018;44(3):277-293. doi: 10.1080/00952990.2017.1355919. Epub 2017 Aug 21.
Previous meta-analytical research examining cocaine and methamphetamine separately suggests potentially different neuropsychological profiles associated with each drug. In addition, neuroimaging studies point to distinct structural changes that might underlie differences in neuropsychological functioning.
This meta-analysis compared the effect sizes identified in cocaine versus methamphetamine studies across 15 neuropsychological domains.
Investigators searched and coded the literature examining the neuropsychological deficits associated with a history of either cocaine or methamphetamine use. A total of 54 cocaine and 41 methamphetamine studies were selected, yielding sample sizes of 1,718 and 1,297, respectively. Moderator analyses were conducted to compare the two drugs across each cognitive domain.
Data revealed significant differences between the two drugs. Specifically, studies of cocaine showed significantly larger effect-size estimates (i.e., poorer performance) in verbal working memory when compared to methamphetamine. Further, when compared to cocaine, methamphetamine studies demonstrated significantly larger effect sizes in delayed contextual verbal memory and delayed visual memory.
Overall, cocaine and methamphetamine users share similar neuropsychological profiles. However, cocaine appears to be more associated with working memory impairments, which are typically frontally mediated, while methamphetamine appears to be more associated with memory impairments that are linked with temporal and parietal lobe dysfunction.
先前分别对可卡因和甲基苯丙胺进行的荟萃分析研究表明,每种药物可能具有不同的神经心理学特征。此外,神经影像学研究指出了不同的结构变化,这些变化可能是神经心理功能差异的基础。
本荟萃分析比较了在15个神经心理学领域的可卡因研究与甲基苯丙胺研究中确定的效应大小。
研究人员检索并整理了有关检查与可卡因或甲基苯丙胺使用史相关的神经心理缺陷的文献。总共选择了54项可卡因研究和41项甲基苯丙胺研究,样本量分别为1718和1297。进行了调节分析以比较两种药物在每个认知领域的情况。
数据显示两种药物之间存在显著差异。具体而言,与甲基苯丙胺相比,可卡因研究在言语工作记忆方面显示出显著更大的效应大小估计值(即表现更差)。此外,与可卡因相比,甲基苯丙胺研究在延迟情境言语记忆和延迟视觉记忆方面显示出显著更大的效应大小。
总体而言,可卡因和甲基苯丙胺使用者具有相似的神经心理学特征。然而,可卡因似乎与工作记忆损害更相关,工作记忆损害通常由额叶介导,而甲基苯丙胺似乎与与颞叶和顶叶功能障碍相关的记忆损害更相关。